California Institute for Regenerative Medicine
ORCID: 0000-0002-9077-7467Publishes on Hematopoietic Stem Cell Transplantation, Immune Cell Function and Interaction, Immunotherapy and Immune Responses. 1.3k papers and 192.6k citations.
Add your photo, update your bio, and get notified when your ranking changes.
A workshop was convened by the AACR to discuss the rapidly emerging cancer stem cell model for tumor development and progression. The meeting participants were charged with evaluating data suggesting that cancers develop from a small subset of cells with self-renewal properties analogous to organ
Mouse bone marrow hematopoietic stem cells were isolated with the use of a variety of phenotypic markers. These cells can proliferate and differentiate with approximately unit efficiency into myelomonocytic cells, B cells, or T cells. Thirty of these cells are sufficient to save 50 percent of lethally irradiated mice, and to reconstitute all blood cell types in the survivors.
Coming soon — researchers in similar fields and career stages